APO 113 Pill - white & yellow capsule/oblong
Pill with imprint APO 113 is White & Yellow, Capsule/Oblong and has been identified as Gabapentin 300 mg. It is supplied by Apotex Corp.
Gabapentin is used in the treatment of Back Pain; Postherpetic Neuralgia; Epilepsy; Chronic Pain; Seizures and belongs to the drug class gamma-aminobutyric acid analogs. Risk cannot be ruled out during pregnancy. Gabapentin 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for APO 113




Gabapentin
- Imprint
- APO 113
- Strength
- 300 mg
- Color
- White & Yellow
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Gamma-aminobutyric acid analogs
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Apotex Corp.
- Inactive Ingredients
-
croscarmellose sodium,
magnesium stearate,
ammonia,
ferrosoferric oxide,
butyl alcohol,
alcohol,
isopropyl alcohol,
potassium hydroxide,
propylene glycol,
water,
shellac,
gelatin,
ferric oxide yellow,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00904-5632 (Discontinued) | Major Pharmaceuticals |
60505-0113 (Discontinued) | Apotex Corp. |
33261-0049 | Aidarex Pharmacuticals, LLC (repackager) |
60429-0739 (Discontinued) | Golden State Medical Supply (repackager) |
68071-0212 | Nucare Pharmaceuticals Inc. (repackager) |
Related images for "APO 113"
More about gabapentin
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2,574)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: gamma-aminobutyric acid analogs
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
- Gabapentin monograph
- Gabapentin (FDA)
- Gabapentin Capsules (FDA)
- Gabapentin Oral Solution (FDA)
- Gabapentin Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.